Modern medical implants such as artificial cardiac pacemakers can communicate wirelessly. This enables patients to track their own health with a smart phone.
A new European research project will explore the earliest origins of cardiovascular and metabolic disease.
A rapid tuberculosis drug resistance test has been developed by European scientists. The test facilitates personalised treatment quicker than ever before.
Alzheimer’s disease is strongly age-related, but the role of ageing in the disease process is remarkably understudied.
How does our body keep its DNA intact? European researchers just found a new piece of this puzzle. They discovered a novel alarm that cells use to signal DNA damage.
Modern medicine is predictive, preventive, personalised and participatory.
Cancer screening programmes save thousands of lives each year. However, critics claim that the programmes lead to overtreatment and are too expensive.
When Jan Geissler was diagnosed with chronic myeloid leukaemia, he was 28. The diagnosis caught him by surprise.
Cardiovascular disease is the leading cause of death among women globally. Scientific research in this field has traditionally focused on men.
The falling costs of gene sequencing and the rise of healthcare monitoring gadgets mean our bodies will generate big data clouds.
European scientists recently discovered a novel therapy to treat a subgroup of breast cancer patients.
As the European baby-boom generation retires the need for products that assist independent living rises.
Diabetes leads to early death and poor quality of life. Patients and healthcare professionals will now be able to partner up and manage the illness in more effective ways.
A new toolkit on screening for chronic viral hepatitis seeks to raise awareness, improve knowledge and motivate public health professionals in Europe to take actions.
The first test of an Ebola vaccine in people suggests that it’s effective and safe.
Retinitis pigmentosa is a group of hereditary disorders that lead to vision loss. European scientists have now explored a potential therapeutic intervention.
Cancer treatments are continually being improved, but cancer is still a major cause of death worldwide.
www.HorizonHealth.eu will conduct a visitor survey in September. “Please let us know what you think”, says editor-in-chief Fred Balvert.
There are dramatic differences in quality of life, health and life expectancy that are closely linked with social injustice.
